Latest News and Press Releases

MONTRÉAL, 13 nov. 2018 (GLOBE NEWSWIRE) -- Les dirigeants de SIRIOS (TSX CROISSANCE: SOI) ont le plaisir d’annoncer les résultats d’analyses de six sondages, totalisant 1 780 mètres, effectués...

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the...

Conference Call Today at 9:00 a.m. Eastern Time NEWTOWN, Pa., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX), a Phase 3 stage biopharmaceutical company focused on...

CALGARY, Alberta and SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic...

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- CityBlock Capital announces a strategic investment from Stonegate Digital Capital Group, the investment arm of Blockchain Financial Group, a diversified...

CAMBRIDGE, Mass., and BEIJING, China, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...

70% of operators say store compliance with operating procedures a primary obstacle SAN FRANCISCO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Zenput, the global leader in operations execution solutions,...

Company reports third quarter net XHANCE revenue of $1.9 million Company reports 42% monthly XHANCE prescription growth from August to October Conference call and webcast to be held today at 8:00...

TEL AVIV, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Planning Phase II Trial VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH)...